ArticleAnnals of internal medicine2009

ACP Journal Club. Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes.

Lorraine LipscombePubMed ↗Publisher ↗

No numbers read from the abstract.